P3 Health Partners Inc.

NASDAQ:PIII

7.81 (USD) • At close May 21, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 373.225370.686362.124379.157388.488346.861288.351329.086302.077258.2248.26269.454273.544490,604.623156.52151.419151.298130.399128.841116.864114.959
Cost of Revenue 0768.7670365.171403.596389.313300.941324.051307.11291.181276.591267.448287.573668.066161.328150.381146.625136.244127.016105.778115.464
Gross Profit 0-398.081362.12413.986-15.108-42.452-12.595.035-5.033-32.981-28.3312.006-14.028489,936.556-4.8081.0384.673-5.8451.82511.087-0.506
Gross Profit Ratio 0-1.07410.037-0.039-0.122-0.0440.015-0.017-0.128-0.1140.007-0.0510.999-0.0310.0070.031-0.0450.0140.095-0.004
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 24.99931.36627.21926.6127.40124.43133.06527.22337.64339.737.86341.09838.59953,336.45520.43418.39115.05916.61713.74311.76911.262
Selling & Marketing Expenses 0.1810.4610.1340.4140.3220.7210.6540.8571.0011.71.121.4080.8651,501.5160.4910.3570.270.8720.2790.1490.203
SG&A 25.1831.82727.35327.02427.72325.15233.71928.0838.64441.438.98242.50639.46454,837.97120.92518.74715.32917.48814.02211.91811.465
Other Expenses 386.133477.362441.76118.296-13.3440.19-0.741312.25289.9269.291.49286.248464,293.780000000
Operating Expenses 411.313509.189469.11445.3228.72321.808322.171350.119350.894331.3308.272330.185325.712519,131.75184.644170.857164.2861.27415.34121.5275.624
Operating Income 0-138.503-106.99-31.334-43.831-64.26-33.82-21.033-48.817-536.5-60.012-912.187-52.16860.55-28.124-19.438-12.988-4.281-13.515-4.663-6.13
Operating Income Ratio 0-0.374-0.295-0.083-0.113-0.185-0.117-0.064-0.162-2.078-0.242-3.385-0.1910-0.18-0.128-0.086-0.033-0.105-0.04-0.053
Total Other Income Expenses Net 014.3070.5353.528-3.703-3.08-3.057-6.323-3.3416.077-5.3189.081-8.622-82.621-3.931-3.493-11.6624.054-2.317-2.3-2.261
Income Before Tax -43.173-124.196-106.455-27.806-47.534-67.34-36.877-27.356-52.158-530.5-65.329-903.106-60.79-31,329.869-34.168-24.968-24.651-0.227-15.831-6.963-8.391
Income Before Tax Ratio -0.116-0.335-0.294-0.073-0.122-0.194-0.128-0.083-0.173-2.055-0.263-3.352-0.222-0.064-0.218-0.165-0.163-0.002-0.123-0.06-0.073
Income Tax Expense -1.0734.952-3.6050.9682.0721.7670.4120.2260.291.9-51.406-746.022-47.452-13.6343.93110.0262.1243.450.876-2.775-1.551
Net Income -42.1-58.617-46.512-12.02-18.7-25.462-13.296-9.816-9.199-94.026-11.173-154.35-10.57776.088-32.054-29.464-24.651-3.677-16.707-4.188-6.84
Net Income Ratio -0.113-0.158-0.128-0.032-0.048-0.073-0.046-0.03-0.03-0.364-0.045-0.573-0.0390-0.205-0.195-0.163-0.028-0.13-0.036-0.059
EPS -12.91-18.02-0.29-0.088-0.16-0.27-0.12-0.091-0.22-2.26-0.27-3.71-0.251.83-0.46-0.43-0.37-0.058-0.25-0.063-0.11
EPS Diluted -12.91-18.02-0.28-0.085-0.16-0.086-0.043-0.091-0.22-2.26-0.046-0.64-0.251.83-0.46-0.43-0.37-0.055-0.25-0.063-0.11
EBITDA -30.846-96.209-79.135-0.677-21.739-41.66-11.154-1.725-26.532-505.308-40.765-878.652-36.277-183.76-27.667-25.541-12.656-4.099-13.269-4.474-5.951
EBITDA Ratio -0.083-0.26-0.219-0.002-0.056-0.12-0.039-0.005-0.088-1.957-0.164-3.261-0.133-0-0.177-0.169-0.084-0.031-0.103-0.038-0.052